MedPath

Investigating the Effect of Chlorine Dioxide and Chlorhexidine Mouthwash on Bad Breath

Not Applicable
Not yet recruiting
Conditions
Halitosis
Interventions
Procedure: Chlorhexidine mouthwash
Procedure: Chlorine dioxide mouthwash
Registration Number
NCT06219226
Lead Sponsor
Semmelweis University
Brief Summary

The ODOR trial will be a single-centric, double-blinded, parallel-group, double-armed pilot randomized controlled trial with a non-inferiority design. The efficacy of hyperpure chlorine dioxide will be compared to chlorhexidine mouthwash. The short-term effect of the mouthwashes will be investigated in a 3-hour-long period. The primary endpoint will be the changes in the organoleptic testing scores.

Detailed Description

Eligible patients will be randomly allocated to two groups in a 1:1 ratio. Necessary data will be collected with prespecified electronic case report forms (REDCap). The statistician will calculate the sample size at the end of the pilot investigation of the first 30-30 patients. If feasible, investigators will continue the study by enrolling more patients.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Organoleptic test score (OLS)>=2 for IOH
  • Patients with at least 20 teeth
  • 8 hours of scented oral hygiene product usage, 4 hours of eating, and 2 hours of drinking restriction
  • on the day of investigation, restriction of alcohol, caffeine, perfume usage, and food intake with characteristic smell
Exclusion Criteria
  • Medical history of systematic and infectious diseases (e.g., hepatitis, HIV, tuberculosis).
  • Antibiotic use within the month before the study's start or during the trial or any regular medication
  • Extraoral halitosis (will be distinguished by observing the nasal breath)
  • Eat foods (like garlic) linked to oral malodor on the day before and the sampling day, as well as wear heavily fragrant cosmetics on that day.
  • Patients with removable dentures
  • Smokers (Cigars, Cigarettes, Pipes, Chewing tobacco, e-cigarette, or vaping products used in the last month)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Chlorhexidine mouthwashChlorhexidine mouthwashParticipants will rinse once with chlorhexidine-containing mouthwash (0.2%).
Chlorine dioxide mouthwashChlorine dioxide mouthwashParticipants will rinse once with hyper-pure ClO2 (0.003%) mouthwash.
Primary Outcome Measures
NameTimeMethod
Changes of the organoleptic testing scoresimmediately after the rinse and 3 hours later

(gold standard 6-point (0-5) intensity scale. The examiner rates it 0 when the patient has no halitosis, and 5 when it is very severe)

Secondary Outcome Measures
NameTimeMethod
Self-perceived halitosisimmediately after the rinse and 3 hours later

with a visual analog scale ratings (0-100, 0 = No Pain, 100 = Worst Possible Pain)

Changes of the volatile sulfur compoundsimmediately after the rinse and 3 hours later

with gas chromatography

© Copyright 2025. All Rights Reserved by MedPath